JFIFC     C   d" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?SOw㎯?<=䮿<2&I ̛n^Δѡc,m6L5[r tWvԵ/ qytmڠlMb9)[MʆrU^:9$ẓ}?R%l֗V3J7ےRrs|=MuFݒ M:^:<Q) KʧMeKy%=/֧<6m5 /;gT?U2vYx.}Ϗ |FO4Oi>"!ԭt'k$%VVդg`2*0:k/%=ߓUxg IUѪ($:۾?i[~n/,M__Sk&Pt[YD\v89bhlu_O'Mk[lIA9 +|cnm.[K y$pXc5wm^?D`^)8SArÐ=zG|ku_Otr\5EC`rAA}E~Oex8I&~N_JjJqODoWeOdSՏ_p}K̀)Zo-+4Khg eΛV A=*H?wy.wjMhH 0Tg xTEi\QjFJZKo9 a l23_՜Ҧڒm/p TwimӺNO4|=u ;O35FNp>qvSR]O`O䲀GgԂ1-.r Ob;e+YMtulF#8f%d͕(kR_k}hlv݂, 3{z4|v|dUU,8'<:ZWz4m=;eWH rqdANH!4bzw&Uc4K84zk9R~魒(c/%$dמqQxq'hV߭eO&&?[Fy' f"xoCfiku$yBcupF$`m-&\CXZ?4_zLSĚd B4bƀGKNOsWo/hM6YCnߥl3(a__|MTxكoY|G%#a~W!}~p}C]Hʙ,ZƋ@5h'.$}0;AA=q%ۍEl[>tZ+݉0c=zt- $I4`$߮qALUx*MWio4yKky;#;cҾ+Cf1[8)[ۢ?s;:5Y)B+)*mwYz\l5Xf7d(" Bs9XW<=k iz!kt%%B "@5o6M(ge&m2V>feU3O弾 [9K|4sMaU syʒzq–0ȭi==7V~ͩ*"ךӊM̗ý'K -ω5[oS8yQ mXh'di$rN?Jm+Q^iN8.Nqv#Yelg%pqq^ڧ(xRE-Q4kw1P  K 4Y]|:5J#n2Z2JZZOHi$|˩izvRTasT-ƾN y鑚:Yi:Y<}Yk/#퇝]]ZZzF#"η+-EP2x4*ՂMO 'moIt~|e~xv߳hV"lo{]:͜D,"1>l>'x|%:ssuT\kM T*{jT )h<6?Iq 3ϐi7-k vAVY$.ёOibb;*zA$F^Z,roJ-]{ǭBš X"' <{v?,̻W\O<eDue7 e{ SV +70^D-!+fQӈR2p@-}YBBR ›U${WVYC1pc(um릺AV`ӻM%kzO{3Q}En,|мqS9eܓzI:11V0]@_q^]umMmJݧ] m^oo+k%*w`pj SVwNEοi:6KbvBioQ*aC<>`(T e# c߽ig_XdwقŘ6H8{:M[]{@L &y$s jjq(`#4ž "XDb- o$ Wԝ,o$|F1"r6\څI;+u6d7eVڴ];XEL-h "Ŏ$ 蠿wnͩZ_j:[}OˋEn߿H=ˆ|Is oU8jM`gsJ`7x&F1mQzipXS4uoԟ3?ZخQE9~EዉgOF$3=ҿ?d]y?KIYRlPzWR]?|c0Ėp8VnuώگMު^T&$<zş3h.}w`{kdOz&WcԮ TW5w/I2|(TGrl~N0c~REKǠK&xI? -"O-c,f뮞]!c^?zZ-z氖B-}1O[+V0 ~U $fO?Z?'$éz.c󆀱\23yimăSvgq͹5Q_ 񗋗%T\9O!}.e?`ͪ:݅!V?h? S>g<[&zb[uB"C|_iQp?,b. Gi. xp? somƩ0sA%T\9O˿|@-ml帝Ingl* ֿo^O2🆣PiV83J^U%:gB~#f[xuxrȈ@ :WtQE ( ( ( ( ( ( ( ( (? s AO or CAG can be used if the parent hasn t been tested. The gender of the affected parent is also important since studies have shown that a gene from the paternal side usually results in a larger CAG repeat length. </P> <P>The final step is based on the probability that the individual is still symptom-free, given the estimated repeat length. At this point, the RRS can be calculated, though counsellors may also consider any children who have been tested and shown to be gene negative.</P> <P>Data was drawn from 755 individuals enrolled in the Dutch cohort study, tested between 1993 and 2000, with a CAG repeat length of more than 35. The study s subjects came from 344 different HD families of which 614 were affected and 141 were asymptomatic gene carriers.</P> <P>Based on the absence of symptoms and family history, the RSS tool can increase the amount of information that genetic counsellors can offer their clients. The tool is an effective one in helping individuals make a decision surrounding predictive testing  whether to test soon or postpone it for a few years.<BR>A copy of the study can be found at <A href="http://www.springerlink.com/content/gx2p65128031m416/?p=cfe5add3370c458db60c5276931e729b&amp;pi=9">here</A>. <BR><BR><STRONG>Partners in Research</STRONG><BR>The Huntington s Disease Society of America (HDSA) is a national, voluntary health organization dedicated to improving the lives of people with HD and their families.&nbsp; The organization strives to promote and support research and medica efforts working to eradicate HD, and also assist those with HD and their families in coping with challenges associated with the disease. </P> <P>The organization is an active one, supporting more than 40 scientists and 16 major HD laboratories in North America and around the world through their HDSA Coalition for the Cure. Twenty-one HDSA Centers of Excellence are located in major hospitals and university medical centres throughout the United States. The national office also produces and distributes, free of charge, publications and informational materials on HD and maintains a toll-free information hotline to assist physicians, patients and family members. </P> <P>HDSA makes itself available throughout 12 regions, 38 volunteer-based chapters and affiliates and more than 200 support groups, reaching out to HD patients and their families by offering guidance, encouragement, resource information and leadership opportunities at HDSA events, meetings and seminars. For more information, visit <A href="http://www.hdsa.org/">www.hdsa.org</A>.</P> <P><BR><STRONG>Dr. Hayden Presentation</STRONG><BR>Dr. Hayden s presentation from January 18, 2009 in Toronto on Personalized Medicine: Hype or Hope- A Canadian Perspective is now available to be viewed on the internet along with his PowerPoint presentation slides.<BR><A href="http://msl.stream.yorku.ca/mediasite/Viewer/Viewers/Viewer320TR.aspx?mode=Default&amp;peid=a3d81791-deba-469e-9660-9ad94d0abafa&amp;pid=8ae2e926-67cf-4be8-afd8-1fe6